ki:elements

RESEARCH BASED INNOVATION

Exploring our

scientific evidence

At ki:elements, we are committed to advancing healthcare and clinical research through scientific innovation. Harnessing our cutting edge technologies, we collaborate with leading researchers, companies and institutions to achieve this goal.

100+ publications in leading journals

Over 50 studies

More than 30,000 participants

8 therapeutic areas

Featured Articles

Alzheimer's

Scientific Article

Speech-based digital cognitive assessment for clinical trials: Detecting cognitive impairment stages and AD biomarker relations across European cohorts

König et al., 2026.

Alzheimer's

Scientific Article

Speech-based digital cognitive assessment for clinical trials: Detecting cognitive impairment stages and AD biomarker relations across European cohorts

König et al., 2026.

Alzheimer's

Scientific Article

Speech-based digital cognitive assessment for clinical trials: Detecting cognitive impairment stages and AD biomarker relations across European cohorts

König et al., 2026.

ALS

Scientific Article

Automatically measured speech intelligibility models bulbar-specific disease severity and progression in Amyotrophic Lateral Sclerosis

Tröger et al., 2025

ALS

Scientific Article

Automatically measured speech intelligibility models bulbar-specific disease severity and progression in Amyotrophic Lateral Sclerosis

Tröger et al., 2025

ALS

Scientific Article

Automatically measured speech intelligibility models bulbar-specific disease severity and progression in Amyotrophic Lateral Sclerosis

Tröger et al., 2025

MDD

Scientific Article

Validating objective and scalable speech markers of depression across two independent psychiatric cohorts

Menne et al., 2026

Alzheimer's

Poster

Speech-based biomarkers for evaluating tau PET status: Insights from the REτAIN study in preclinical Alzheimer’s disease

Kyani et al., 2026

Alzheimer's

Poster

Speech-Based Biomarkers for Assessing Cognitive Status in Preclinical Alzheimer’s Disease: Insights from the REτAIN Study

Kyani et al., 2026

Alzheimer's

Poster

Longitudinal remote speech biomarkers enable early detection of Alzheimer’s disease pathology-related cognitive change in individuals with Subjective Cognitive Decline

Porta-Mas et al., 2026

Alzheimer's

Poster

Incremental value of a remote speech-based biomarker beyond plasma p-tau217 for predicting one-year PACC scores in individuals with Subjective Cognitive Decline

Porta-Mas et al., 2026

Alzheimer's

Poster

Cultural Influences on Speech-Based Cognitive Assessment: Insights from an Egyptian Cohort

Schäfer et al., 2026

Alzheimer's

Poster

Cross-Cultural Transferability of Speech Biomarkers: Linguistic Adaptation, Model Generalization, and Global Implementation

Tang et al., 2026

Alzheimer's

Poster

Longitudinal Speech-based Cognitive Trajectories Of Csf Biomarker-positive Versus Biomarker-negative Individuals

Alexopoulou et al., 2026

Alzheimer's

Poster

Remote Speech-Based Digital Cognitive Markers Capture Longitudinal Change Beyond Standard Clinical Measures

Alexopoulou et al., 2026

MDD

Scientific Article

Validating objective and scalable speech markers of depression across two independent psychiatric cohorts

Menne et al., 2026

Alzheimer's

Poster

Speech-based biomarkers for evaluating tau PET status: Insights from the REτAIN study in preclinical Alzheimer’s disease

Kyani et al., 2026

Alzheimer's

Poster

Speech-Based Biomarkers for Assessing Cognitive Status in Preclinical Alzheimer’s Disease: Insights from the REτAIN Study

Kyani et al., 2026

Alzheimer's

Poster

Longitudinal remote speech biomarkers enable early detection of Alzheimer’s disease pathology-related cognitive change in individuals with Subjective Cognitive Decline

Porta-Mas et al., 2026

Alzheimer's

Poster

Incremental value of a remote speech-based biomarker beyond plasma p-tau217 for predicting one-year PACC scores in individuals with Subjective Cognitive Decline

Porta-Mas et al., 2026

Alzheimer's

Poster

Cultural Influences on Speech-Based Cognitive Assessment: Insights from an Egyptian Cohort

Schäfer et al., 2026

Alzheimer's

Poster

Cross-Cultural Transferability of Speech Biomarkers: Linguistic Adaptation, Model Generalization, and Global Implementation

Tang et al., 2026

Alzheimer's

Poster

Longitudinal Speech-based Cognitive Trajectories Of Csf Biomarker-positive Versus Biomarker-negative Individuals

Alexopoulou et al., 2026

Stay Up to date

Follow our lead scientists on Google Scholar

Dr. Alexandra König

Chief Clinical Research Officer

Dr. Johannes Tröger

Chief Scientific Officer

Dr. Tabea Thies

Clinical Researcher, Movement Disorders

Dr. Felix Menne

Clinical Researcher, Psychiatry

Pioneers in speech biomarkers

Therapeutic Areas

Alzheimer's Disease

ALS/MND

Parkinsonian Syndromes

Schizophrenia

Major Depressive Disorder

Data Protection Notice

Legal Information

Pioneers in speech biomarkers

Therapeutic Areas

Alzheimer's Disease

ALS/MND

Parkinsonian Syndromes

Schizophrenia

Major Depressive Disorder

Data Protection Notice

Legal Information

Pioneers in speech biomarkers

Therapeutic Areas

Alzheimer's Disease

ALS/MND

Parkinsonian Syndromes

Schizophrenia

Major Depressive Disorder

Data Protection Notice

Therapeutic Areas

Partner with us